Introduction
Early treatment of hypothyroid neonates is essential to prevent mental retardation. This goal can be achieved by neonatal hypothyroidism screening which has proved to be a rapid and effective method to detect hypothyroid newborns [3] . In pregnancies at risk for the presence of fetal hypothyroidism, such as hyperthyroid mothers accidentally treated with 131 I after 10 weeks of pregnancy or treated with antithyroid drugs, it seems reasonable to make an in utero diagnosis of fetal hypothyroidism. Medical treatment of the hypothyroid fetus by the administration of thyroxine (T4) into the amniotic cavity or intramuscularly may be effective [17, 28] although cord blood (CB) TV and Ts concentrations were undetectable and TSH concentration was elevated in the fetus treated intramuscularly [17] . The diagnosis of intrauterine hypothyroidism has been attempted by measurement of T4 or FBI in amniotic fluid (AF) resulting in values apparently reflecting thyroid function in the neonate [10] . However, the concentrations of T4 and triiodothyronine (Ts) in unconcentrated AF are low or undetectable and, therefore, these tests may not be clinically useful in detecting fetal hypothyroidism [4, 26] . Measurement of AF reverse Ts (rTs) has been proposed as a useful method to detect fetal hypothyroidism [4] . However, low AF rTs was not useful in detecting a few patients with proven fetal hypothyroidism [16] . More recently it has been suggested that meas-times of TRH injection, CB and AF sampling urement of AF thyrotropin (TSH) could be a were recorded. AF specimens contaminated reliable test to diagnose primary fetal hy-with blood or meconium were not included, pothyroidism [27] , although this is somewhat Only AF which was clear by visual inspection controversial [21] . In support of this possibility, was evaluated. Portions of all the AF specimens KOURIDES et al. have reported that TSH can be were concentrated 4 fold by lyophilization and detected in 3 to 8 fold concentrates of AF and then reconstituted in 0.01 M Na P 4, pH 7.4, have suggested that an elevation of AF TSH 0.25% bovine serum albumin buffer. Serum may be useful in the diagnosis of primary fetal and AF specimens were kept frozen at -20 °C hypothyroidism [13] . The present study was until analysis. Except for a few specimens, TSH, undertaken to determine whether fetal T4, Ta and rH were measured in all CB and hyperthyrotropinemia, induced by the ad-unconcentrated AF samples. TSH was also ministration of thyrotropin releasing hormone measured in the concentrated AF samples. (TRH) to the mothers during labor [23] , would Hormone ana i yses: T SH was measured by RIA result in an increase in AF TSH concentrations mi materials obtained from the National obtained during labor and delivery.
Pituitary Agency, NIAMDD (Bethesda, MD); 300 μΐ of serum or AF or buffer were employed in the TSH assay. The protein content in clear, 2 Material and methods concentrated AF was approximately 250 mg/ dl, 92 percent of which is albumin. The diluent After informed consent was obtained by the f or the standard curve used in the measurement obstetrician prior to labor, 65 women with of AF TSH consist ed of phosphate buffer, uncomplicated pregnancies were studied at 0 01 M> pH 7 4? enriched with human serum term. Sixteen received an iv injection of 2 ml of albumin (H SA) to approximate the consaline and the others, selected at random, were centration of protein in AF. This concentration treated with 400 μ § synthetic TRH iv (Biodata, of HSA did not affect the standard curve . The Milan, Italy). After the umbilical cord was cut, recover y o f human TSH added to AF is 100 CB was obtained from the placental side of per cent. The lowest detectable TSH conthe cord which represents fetal blood and is a centration was 0 .2 μυ/tube corresponding to mixture of arterial and venous blood. Samples 0 6 μυ/ηι1 Τ4 was measured in serum and A F of amniotic fluid were obtained in one of 2 by RIA using materia i supplied by Biodata. ways. In the 31 women who were delivered by Semm and AF Ta and rTs were measure d by Caesarian section, amniocentesis was per-methods previously described [1, 19] . Sensitivity formed through the fetal membranes after o f the assays for the thyroid hormones are: T 4 , uterine incision. Ammorexis is a common 0 6 μβ / α1; y 3 62 / dl; τΎ^ 25 /dl practice during labor in these obstetrical units. Therefore, in the 34 women who were delivered M samples were assayed for each hormone in vaginally, amniocentesis was carried out under duplicate, in the same assay and in random direct visualization through the fetal sac after OI> der. it protruded through the dilated cervical os. In Data analysis: Hormone values in CB and AF some women, vaginal amniocentesis was samples from mothers treated with saline were carried out on 2 occasions. In both groups of assigned to one group (group 0). Hormone conwomen, AF was obtained only if a sufficient centrations in CB and AF specimens from volume of AF was interposed between the fetus women treated with TRH were assigned to difand fetal membranes. All amniocenteses were ferent groups (1 to 5) depending upon the duracarried through a 140 mm, 0.7 mm gauge tion of time between TRH administration and needle. No adverse effects were observed during CB and AF samples. There was no significant labor and delivery or during the neonatal difference in gestational age or birth weight period following TRH administration. The among the various groups.
Statistical analysis was carried out by one way analysis of variance (ANOVA, F test) and Duncan's multiple range test corrected for an unequal number of determinations [14] to compare the value of group 0 (saline treated) and groups 1 to 5 (TRH treated). All results are reported as the mean + SE.
Results
TSH concentrations in CB and in unconcentrated AF are shown in Fig. 1 . In group 0, CB TSH was 5.0 ± 0.3 μΠ/ml. A significant variation in CB TSH concentration was observed in groups whose mothers received TRH (p < 0.01, F test). A peak value of 38.0 + 4.2 μυ/ml was observed in group 2, sampled from 61 to 120 min after TRH. This value was highly significant vs values obtained in group 0 (p < 0.01, Duncan's test). A significant increase in TSH, as compared to group 0, was observed in groups 1 and 3 (p < 0.01, Duncan's test) and also in group 4 sampled from 181 to 240 min after TRH (p < 0.05, Duncan's test). TSH was below the limit of detectability in unconcentrated AF samples obtained from all groups. TSH was also undetectable in AF samples concentrated 4 fold except for two specimens sampled at 75 and 140 min after TRH administration (1.3 and 1.0 μυ/ml, respectively) and in three samples in group 0 with values of 1.0 μυ/ml. In AF specimens contaminated with blood, not included in these groups, TSH concentrations as high as 2.3 μΐΐ/ ml were observed. The concentrations of T4, TB and rTs in cord blood confirmed our earlier findings (23) (Tab. I). In group 0, the mean T4 concentration was 10.9 ± 0.5 μg/dl. In groups 1 to 5, a significant increase was observed p < 0.01 (F test) with a peak value of 14.7 ± 0.9 μg/dl in group 4 
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Discussion
Neonatal thyroid screening has provided a useful tool for the detection of hypothyroid newborns resulting in early treatment of these infants, thus avoiding permanent mental retardation due to thyroid hormone deficiency during the neonatal period. However, possible approaches to the intrauterine diagnosis of fetal hypothyroidism have been suggested [27] . Measurement of rTs in AF was proposed as a possible approach to evaluate fetal thyroid function [9] . However, later studies have indicated that this test was not useful in diagnosing fetal hypothyroidism [16] . In the rat, it has been demonstrated that AF rTs is more dependent upon maternal thyroid function than fetal thyroid status [6] and it has been postulated that fetal rTs arises, at least in part, from the inner ring deiodination of T4 by placenta and fetal membranes [22, 24, 25] .
Recently, KOURIDES et al. [13] have detected TSH in 3 to 8 fold concentrates of AF suggesting the possibility of diagnosing primary fetal hypothyroidism. In a previous study we were able to detect TSH in only a few specimens of AF [20] . In the present report, TSH was not detectable in the unconcentrated AF samples. After a 4 fold concentration, TSH was still undetectable in almost all AF samples obtained in saline and TRH treated women at term. These conflicting results are probably due to the different sensitivities of the two TSH assays, 0.15μυ/πι1 [10] vs 0.6 μυ/ml (present study).
The aim of the present study, however, was to evaluate whether a marked increase in fetal serum TSH would result in a corresponding elevation in AF TSH. After the administration of TRH to the term pregnant woman, CB TSH concentrations were markedly increased, reaching values as high as 63.3 μυ/ml. This increase in CB TSH did not result in a detectable increase in AF TSH even when the AF was concentrated 4 fold. In the adult, TSH has a biological half life of 50 -60 minutes and is mainly metabolized by the kidney. Moreover, immunoreactive TSH is not found in the urine [5] .
In the newborn, the half life of endogenous TSH is 77 minutes [8] . It is not known how fetal TSH reaches the amniotic fluid. In a previous study, AF TSH measured before T4 injection into the amniotic cavity was undetectable in suspected fetal hypothyroidism due to maternal treatment with 131 I at 10 -11 weeks of pregnancy [17] . In other cases of proven fetal hypothyroidism, AF TSH unfortunately was not measured [16, 7] . HOLLINGSWORTH et al. have reported high concentrations of AF TSH in the sheep following fetal hypothyroidism induced by intrauterine thyroidectomy [11] . The presence of high concentrations of TSH in AF may be due to the different placental structure in the sheep compared to man. The ovine placenta consists of separate cotyledons whereas the human placenta is a single mass. Furthermore, although unlikely, serum TSH could have reached the AF through the surgical thyroidectomy scar. In the present study, AF TSH was elevated in saline and TRH treated women when the AF samples were contaminated with blood.
Although elevations of fetal serum TSH concentrations for as long as 4 hours did not result in elevated AF TSH concentrations in the present study, it should be emphasized that fetal hypothyroidism is most often due to thyroid agenesis or dysgenesis [15] which would result in a more prolonged and greater elevation of fetal serum TSH. Whether the longer duration of an even higher elevation of fetal serum TSH concentrations would result in an increase in AF TSH remains conjectural. It should also be emphasized that the present study was carried out in the term fetus and it is possible that elevations in serum TSH in mid gestation might result in an increase in TSH content in the amniotic fluid at that time. However, since this study was completed, HOLLINGSWORTH and ALEXANDER reported that measurements of AF concentrations of thyroid hormones and TSH do not reliably predict fetal or neonatal thyroid status [12] .
Summary
Cord blood and amniotic fluid thyrotropin (TSH), T4, Ta, and rTs concentrations were measured in 49 women who received 400 § thyrotropin releasing hormone (TRH) iv during labor and in 16 control women who received saline. Cord blood serum TSH concentrations were elevated for as long as 4 hours after TRH administration and peak values (38.0 ± 4.2 /ml) were observed from 61 -120 minutes after TSH as compared to control values of 5.0 ± 0.3 /ml. The elevations in fetal TSH concentration stimulated the fetal thyroid, resulting in a progressive increase in cord blood T4 and Ts but not rTs concentrations. These TRH induced elevations in fetal cord blood TSH concentrations were not accompanied by increases in unconcentrated and 4 fold concentrated amniotic fluid TSH concentrations which were almost always below 0.6 /ml, the limit of assay sensitivity. Unconcentrated amniotic fluid T4 concentrations were barely detectable and no variation was observed between the TRH treated and saline treated mothers; amniotic fluid Ta was not detectable in any of the groups; and amniotic fluid rTs concentrations ranged between 46.4 and 55.6 ng/dl and did not differ between groups. These findings suggest that term amniotic fluid TSH values do not reflect transient but marked elevations in fetal serum TSH concentrations and that amniotic fluid TSH determination is probably not useful in the detection of primary fetal hypothyroidism. It is possible, but unlikely, that long-term and even greater elevations in fetal serum TSH concentrations would result in increased amniotic fluid TSH concentrations. Thus, there appears to be little use in measuring amniotic fluid TSH concentrations for diagnosing fetal hypothyroidism.
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Zusammenfassung

TSH im Fruchtwasser nach Gabe von TRH an die Mutter
In 49 Fällen, in denen die Mutter unter der Geburt 400 g TRH erhalten hatte, wurden im Nabelblut und im Fruchtwasser die Konzentrationen von TSH, T4, Ta und rT3 bestimmt. Die Kontrollgruppe mit 16 Frauen erhielt NaCl. Die TSH-Konzentration im Nabelblut war bis zu 4 h nach der TRH-Gabe erhöht. Peaks (38.0 ± 4.2 /ml) zeigten sich zwischen 61 -120min nach TRH-Gabe; in der Kontrollgruppe lagen die Peaks bei 5.0 ± 0.3 /ml. Die erhöhte fetale TSH-Konzentration führte über die Stimulation der Schilddrüse zu einem steilen Anstieg von Ts und T4, nicht aber rTs im Nabelblut. Dagegen waren die TSH-Werte sowohl in nichtkonzentriertem wie auch in vierfach konzentriertem Fruchtwasser nicht erhöht; sie lagen immer unter der Nachweisgrenze von 0. 
